Echo Therapeutics Inc (NASDAQ:ECTE)

1.80
Delayed Data
As of Jul 02
 +0.02 / +1.12%
Today’s Change
0.39
Today|||52-Week Range
3.00
+33.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues447.2K5.1K27.6K57.3K
 
 
 
 
 
Depreciation And Amortization47.9K145.2K391.6K392.7K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses8.7M14.9M19.3M12.0M
 
 
 
 
 
Research And Development3.8M8.7M11.3M5.0M
 
 
 
 
 
Total Operating Expenses8.7M15.0M19.7M12.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.3M-15.0M-19.6M-12.3M
 
 
 
 
 
Extraordinary Credit0.003.7M4.5M911.0K
 
 
 
 
Extraordinary Charge-1.8M0.000.00--
 
 
Interest Expense On Debt13.9K959.9K3.9M3.6M
 
 
 
 
 
Other Expenses-1.3K-21.3K0.00774.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.0M-12.3M-19.1M-15.0M
 
 
 
 
 
Income Taxes0.000.000.00-4.0K
 
 
Preferred Dividend-6.7M0.00-371.1K-350.0K
 
 
 
 
Net Income-10.0M-12.3M-19.1M-15.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.4M4.0M8.4M12.3M
 
 
 
 
 
Shares To Calculate EPS Diluted3.4M4.0M8.4M12.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.90-$3.10-$2.33-$1.24
 
 
 
 
 
EPS Diluted-$4.90-$3.10-$2.33-$1.24
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account